These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28644732)

  • 1. Lipophilicity and biomimetic properties to support drug discovery.
    Tsopelas F; Giaginis C; Tsantili-Kakoulidou A
    Expert Opin Drug Discov; 2017 Sep; 12(9):885-896. PubMed ID: 28644732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fast gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol/water and immobilized artificial membrane lipophilicity.
    Valko K; Nunhuck S; Bevan C; Abraham MH; Reynolds DP
    J Pharm Sci; 2003 Nov; 92(11):2236-48. PubMed ID: 14603509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipophilicity and biomimetic properties measured by HPLC to support drug discovery.
    Valkó KL
    J Pharm Biomed Anal; 2016 Oct; 130():35-54. PubMed ID: 27084527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in immobilized artificial membrane (IAM) chromatography for novel drug discovery.
    Tsopelas F; Vallianatou T; Tsantili-Kakoulidou A
    Expert Opin Drug Discov; 2016; 11(5):473-88. PubMed ID: 26966996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accessing lipophilicity of drugs with biomimetic models: A comparative study using liposomes and micelles.
    Loureiro DRP; Soares JX; Lopes D; Macedo T; Yordanova D; Jakobtorweihen S; Nunes C; Reis S; Pinto MMM; Afonso CMM
    Eur J Pharm Sci; 2018 Mar; 115():369-380. PubMed ID: 29366962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of lipophilicity in drug discovery and design.
    Arnott JA; Planey SL
    Expert Opin Drug Discov; 2012 Oct; 7(10):863-75. PubMed ID: 22992175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Lipophilicity in Drug Discovery: Rapid Measurements by Means of Reversed-Phase HPLC.
    Giaginis C; Tsopelas F; Tsantili-Kakoulidou A
    Methods Mol Biol; 2018; 1824():217-228. PubMed ID: 30039409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipophilicity--methods of determination and its role in medicinal chemistry.
    Rutkowska E; Pajak K; Jóźwiak K
    Acta Pol Pharm; 2013; 70(1):3-18. PubMed ID: 23610954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomimetic chromatographic analysis of selenium species: application for the estimation of their pharmacokinetic properties.
    Tsopelas F; Tsantili-Kakoulidou A; Ochsenkühn-Petropoulou M
    Anal Bioanal Chem; 2010 Jul; 397(6):2171-80. PubMed ID: 20358187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between immobilized artificial membrane (IAM) HPLC data and lipophilicity in n-octanol for quinolone antibacterial agents.
    Barbato F; Cirocco V; Grumetto L; Immacolata La Rotonda M
    Eur J Pharm Sci; 2007 Aug; 31(5):288-97. PubMed ID: 17540545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative measures of lipophilicity: from octanol-water partitioning to IAM retention.
    Giaginis C; Tsantili-Kakoulidou A
    J Pharm Sci; 2008 Aug; 97(8):2984-3004. PubMed ID: 18553641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retention Behavior of Anticancer Thiosemicarbazides in Biomimetic Chromatographic Systems and In Silico Calculations.
    Studziński M; Kozyra P; Pitucha M; Senczyna B; Matysiak J
    Molecules; 2023 Oct; 28(20):. PubMed ID: 37894587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of volume of distribution in humans from high throughput HPLC-based measurements of human serum albumin binding and immobilized artificial membrane partitioning.
    Hollósy F; Valkó K; Hersey A; Nunhuck S; Kéri G; Bevan C
    J Med Chem; 2006 Nov; 49(24):6958-71. PubMed ID: 17125249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of high-performance liquid chromatography based measurements of lipophilicity to model biological distribution.
    Valkó K
    J Chromatogr A; 2004 May; 1037(1-2):299-310. PubMed ID: 15214672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different retention behavior of structurally diverse basic and neutral drugs in immobilized artificial membrane and reversed-phase high performance liquid chromatography: comparison with octanol-water partitioning.
    Vrakas D; Giaginis C; Tsantili-Kakoulidou A
    J Chromatogr A; 2006 May; 1116(1-2):158-64. PubMed ID: 16595136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of lipophilicity from immobilized artificial chromatography and n-octanol/buffer systems].
    Sun J; Cheng G; He ZG; Wang SJ
    Yao Xue Xue Bao; 2003 Oct; 38(10):791-4. PubMed ID: 14730907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipophilic and electrostatic forces encoded in IAM-HPLC indexes of basic drugs: their role in membrane partition and their relationships with BBB passage data.
    Grumetto L; Carpentiero C; Barbato F
    Eur J Pharm Sci; 2012 Apr; 45(5):685-92. PubMed ID: 22306648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High performance affinity chromatography (HPAC) as a high-throughput screening tool in drug discovery to study drug-plasma protein interactions.
    Vuignier K; Guillarme D; Veuthey JL; Carrupt PA; Schappler J
    J Pharm Biomed Anal; 2013 Feb; 74():205-12. PubMed ID: 23245252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-phospholipid interactions. 2. Predicting the sites of drug distribution using n-octanol/water and membrane/water distribution coefficients.
    Barton P; Davis AM; McCarthy DJ; Webborn PJ
    J Pharm Sci; 1997 Sep; 86(9):1034-9. PubMed ID: 9294818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
    Meanwell NA
    Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.